Crystalvue Medical Corporation (TPEX:6527)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.50
-1.50 (-1.95%)
At close: Mar 9, 2026
-12.21%
Market Cap 1.91B
Revenue (ttm) 949.05M
Net Income (ttm) 146.98M
Shares Out 25.34M
EPS (ttm) 5.70
PE Ratio 13.25
Forward PE n/a
Dividend 2.25 (2.92%)
Ex-Dividend Date Jul 24, 2025
Volume 34,337
Average Volume 16,464
Open 73.00
Previous Close 77.00
Day's Range 73.00 - 75.50
52-Week Range 68.60 - 93.00
Beta 0.89
RSI 49.56
Earnings Date Mar 3, 2026

About Crystalvue Medical

Crystalvue Medical Corporation designs, produces, and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan. [Read more]

Sector Healthcare
Founded 2009
Employees 109
Stock Exchange Taipei Exchange
Ticker Symbol 6527
Full Company Profile

Financial Performance

In 2025, Crystalvue Medical's revenue was 949.05 million, an increase of 9.33% compared to the previous year's 868.03 million. Earnings were 146.98 million, an increase of 15.59%.

Financial Statements

News

There is no news available yet.